Transcatheter aortic valve replacement (TAVR) is a viable option in the treatment of severe
aortic stenosis in patients at high risk for surgery. We sought to further investigate outcomes …

Importance Medically treated symptomatic severe aortic stenosis has poor outcomes, and in
the past 6 decades, it has successfully been treated with surgical aortic valve replacement …

Background Although transcatheter aortic valve replacement (TAVR) is officially indicated for
high risk aortic stenosis (AS) patients, the procedure is increasingly being performed in …

Aortic stenosis (AS) is the most common type of valvular heart disease in the elderly.
Surgical aortic valve replacement (SAVR) has been the standard practice for treating severe …

Background The use of transcatheter aortic-valve replacement has been shown to reduce
mortality among high-risk patients with aortic stenosis who are not candidates for surgical …

Objective Transcatheter aortic valve implantation (TAVI) has emerged as an alternative
treatment to aortic valve replacement (AVR) for selected patients with severe aortic stenosis …

BACKGROUND: Limited real-world data comparing outcomes after transcatheter (TAVR)
and surgical aortic valve replacement (SAVR) in intermediate-surgical-risk patients with …

OBJECTIVES: The aim of the current Valve Academic Research Consortium (VARC)-2
initiative was to revisit the selection and definitions of transcatheter aortic valve implantation …

Transcatheter aortic valve replacement (TAVR) has been recognized as a well-established
alternative to surgical aortic valve replacement (SAVR) for symptomatic aortic stenosis with …

Objective Decision making for intervention in symptomatic aortic stenosis should balance
the risks of surgery and of transcatheter aortic valve implantation (TAVI). We identified the …